(Q39842487)

15 September 2017

Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study (English)

1 reference

15 September 2017

1 reference

1 reference

4

Alan R Zinsmeister

1 reference

15 September 2017

5

Michael Camilleri

1 reference

15 September 2017

10

Claudio Cobelli

1 reference

15 September 2017

2

Chiara Dalla Man

1 reference

15 September 2017

11

Adrian Vella

1 reference

15 September 2017

7

Jeanette M Laugen

1 reference

15 September 2017

1

Airani Sathananthan

1 reference

15 September 2017

3

Francesco Micheletto

1 reference

15 September 2017

8

Gianna Toffolo

1 reference

15 September 2017

6

Paula D Giesler

1 reference

15 September 2017

Robert A Rizza

9

1 reference

PMC publication ID

2928367

15 September 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

15 September 2017

1 reference

15 September 2017

33

1 reference

15 September 2017

9

1 reference

15 September 2017

2074-2076

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

15 September 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A model of GLP-1 action on insulin secretion in nondiabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

Genomics of type 2 diabetes mellitus: implications for the clinician

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

Extrapancreatic effects of GIP and GLP-1.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

More powerful procedures for multiple significance testing

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928367

20 August 2018

Identifiers

DOI

10.2337/DC10-0200

1 reference

15 September 2017

0 references

1 reference

PMC publication ID

2928367

15 September 2017

PubMed publication ID

20805279

1 reference

PMC publication ID

2928367